- Home
- CIA vs CATX Comparison
CIA vs CATX Comparison
Compare CIA & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIA | CATX |
|---|---|---|
| Founded | 1969 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.0M | 211.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CIA | CATX |
|---|---|---|
| Price | $5.98 | $4.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $11.78 |
| AVG Volume (30 Days) | 87.5K | ★ 7.2M |
| Earning Date | 03-12-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $247,020,000.00 | $1,075,000.00 |
| Revenue This Year | $3.65 | N/A |
| Revenue Next Year | $3.51 | N/A |
| P/E Ratio | $28.47 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.90 | $1.60 |
| 52 Week High | $6.36 | $6.16 |
Technical Indicators
Market Signals| Indicator | CIA | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 63.57 | 68.66 |
| Support Level | $5.83 | $4.44 |
| Resistance Level | $6.06 | $5.00 |
| Average True Range (ATR) | 0.31 | 0.81 |
| MACD | 0.03 | 0.08 |
| Stochastic Oscillator | 100.00 | 68.42 |
Price Performance
Historical ComparisonAbout CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.